| Document |
Document Title |
|
WO/2000/008495 |
The present invention provides a compound selected from the group consisting of (I), (II), and (III), wherein R?1¿ and R?4¿ are the same or different and are each H, C¿1?-C¿3? alkyl, phosphate, or C¿1?-C¿3? alkyl carboxylate; R?2¿...
|
|
WO/2000/002455 |
Hypericin has been shown to specifically inhibit T-type calcium channel activity. $i(Hypericum) extract containing hypericin also inhibits T-type calcium channel activity. Moreover, other chemicals in $i(Hypericum) extract showed a syner...
|
|
WO/1999/061409 |
A compound which consists of a proactive alkylating moiety containing an electron-withdrawing group, a bioreductive moiety containing at least two double bonds, and a linker joining the proactive alkylating moiety and the bioreductive mo...
|
|
WO/1999/052819 |
The invention relates to the anthraquinone cycle for producing hydrogen peroxide using at least two differently substituted 2-alkylanthraquinones and/or their tetrahydro derivatives. According to the inventive method, the working solutio...
|
|
WO/1999/050434 |
The strain of the microorganism Penicillium oxalicum var. Armeniaca CCM 8242 produces an anthraquinonyl carboxylic acid derivative of structural formula (I), which may be used as a colorant, especially as a food colorant or cosmetic colo...
|
|
WO/1999/048491 |
NF-$g(k)B inhibitors containing as the active ingredient benzoquinone derivatives represented by general formula (I), hydroquinone compounds thereof or salts of the same, wherein R¿1?, R¿2? and R¿3? independently represent each H, C¿...
|
|
WO/1999/006347 |
Use of 1,3,4,6-tetrahydroxy-helianthrone and substituted derivative thereof as photoactivators for the photodynamic therapy of tumors. There are also provided novel substituted derivatives of 1,2,4,6-tetrahydroxy-helianthrone.
|
|
WO/1998/039337 |
Process for synthesising pure enantiomer anthracycline. Compounds of formula (I) can be produced by using compounds of formulas (II) and (III).
|
|
WO/1998/033758 |
A compound of formula (I), wherein R?1� and R?2� each represents a lower alkyl, or R?1� and R?2� may be bonded together to form a ring; X represents a spacer of which the number of atoms constituting the principal chain is 1 to 1...
|
|
WO/1998/033757 |
The invention concerns a novel method for preparing substituted anthraquinone represented by the general formula (I) in which R represents a hydrogen atom or a linear or branched alkyl group of 1 to 5 carbon atoms, a chloromethyl group, ...
|
|
WO/1998/023689 |
This invention relates to new blue anthraquinone colorants having Formula (I) wherein R and R�1? are the same or different and are selected from hydrogen and unsubstituted or substituted C1-C6 alkyl, C3-C7 cycloalkyl 2-furyl, 2-thienyl...
|
|
WO/1998/012313 |
A transformant prepared by constructing a plasmid wherein a human-inducible nitric oxide synthase (hiNOS) structural gene has been substituted by a luciferase structural gene which is a reporter gene while sustaining the functions of the...
|
|
WO/1998/008522 |
Multivitamin products targeted to specific groups.
|
|
WO/1997/031936 |
A novel synthetic method, novel compounds formed using the synthetic method, and uses for the compounds so made are described. The synthetic method results in the formation of o-naphthoquinone derivatives. These compounds find use as pot...
|
|
WO/1997/021684 |
The therapeutical use of tricyclic derivatives and pharmaceutically acceptable salts thereof having general formula (I), for treating diseases related to venous function deficiency and/or inflammatory oedema, is disclosed. In general for...
|
|
WO/1997/016404 |
A novel method for preparing substituted anthraquinones of general formula (I), wherein R is hydrogen atom or a straight or branched C1-5 alkyl group, a chloromethyl group, a -COCl group, a -COOR' group or a -CH2OR' group where R' is a h...
|
|
WO/1997/008262 |
This invention provides an aggregate of a compound capable of forming helical structures such that the aggregate is capable of achieving a specific rotation of at least 100,000� for plane polarized light having a wavelength of 589 nm.
|
|
WO/1997/003940 |
The present invention relates to a novel 6-substituted-5,8-dioxy-1,4-naphthoquinone derivative having formula (I), which is useful as an anticancer agent. In said formula, R1 represents alkyl; R2 represents hydrogen, alkyl or acyl; and R...
|
|
WO/1997/002271 |
This invention relates to certain naphthoquinone derivatives of general formula (1) or a salt thereof, in which m, n, R, R1, R2, R3, R4, R5, R6, R7, R8 are as defined in the description; processes for their preparation; compositions cont...
|
|
WO/1997/000675 |
The use of the compounds of formula (I), wherein the groups are as defined in the disclosure, for the preparation of medicaments for the treatment of pathologies in which the erosion of the cartilaginous and bone matrix occurs.
|
|
WO/1996/039130 |
Novel terpenoid-type quinones which can be obtained from Pycnanthus spp., processes for obtaining the novel terpenoid-type quinones and methods for their use as hypoglycemic agents, for example, in the treatment of diabetes are described...
|
|
WO/1996/029297 |
A method of making a mesoporous silicate molecular sieve having a framework wall thickness of at least about 17 angstroms, comprising preparing solutions of neutral amine or diamine templating agents, neutral metal silicate precursors an...
|
|
WO/1996/028410 |
A method comprising breaking down a complex of 2-(4'-ethylbenzoyl)benzoic acid, nHF and mBF3 to almost completely eliminate HF and BF3. The remaining solid is cyclised in concentrated sulphuric acid or oleum into non-pure 2-ethyl-anthraq...
|
|
WO/1996/022075 |
The object of the invention is the use of diketo compounds of the formula (I) in which X is a saturated or unsaturated alkylene radical with 2 to 4 C atoms, which may be substituted by halogen, hydroxy, C1-C4 alkoxy, C1-C4 alkyl, C1-C4 h...
|
|
WO/1996/021355 |
Pesticidal compounds having general formula (I) or a salt thereof is provided, in which n represents an integer from 0 to 4; m represents an integer 0 or 1; each R independently represents a halogen atom or a nitro, cyano, hydroxyl, alky...
|
|
WO/1996/021354 |
Pesticidal as a pesticide against whitefly, Lepidoptera and certain fungi is provided of compound of general formula (I) or a salt thereof is provided, in which n represents an integer from 0 to 4; m represents an integer 0 or 1; each R ...
|
|
WO/1996/010005 |
A process for catalytically dehydrogenating an anthrahydroquinone to form anthraquinone and a hydrogen product. A catalyst which is a metal, a metal compound, or a metal or metal compound dispersed on a support or is a liquid is selected...
|
|
WO/1996/007731 |
A method for transfection of cultured mammalian cells is provided. Nucleic acid is mixed with polylysine and hypericin (or a hypericin analog), and a complex is formed. The complex is then contacted with cultured mammalian cells to deliv...
|
|
WO/1996/004895 |
The present invention provides the new use in the treatment of amyloidosis with the anthracyclinone of formula (A) wherein R1, R2, R3, R4 and R5, are appropriate substituents. Some compounds of formula (A) are novel. Processes for their ...
|
|
WO/1996/004230 |
Terpene-quinone with antitumor activity defined from a cyclocondensation reaction of Diels-Alder, used to obtain families or series of said compounds having a new structure and presenting a cytotoxic activity to cellular cultures P-388, ...
|
|
WO/1996/004292 |
8-fluoro-anthracyclines of formula (I) having cis-stereochemistry between the groups 8-F and 9-OH, are described, such compounds present anti-tumor activity. Their preparation and pharmaceutical compositions containing them are also desc...
|
|
WO/1995/032176 |
The invention relates to certain naphthoquinone derivatives, some of which are novel, of general formula (I) in which R represents a hydrogen atom or a hydroxyl or an ethanoyloxy group; methods for their preparation; compositions contain...
|
|
WO/1995/030646 |
The present invention relates to compounds which are useful as sunscreens. The compounds persists on the skin for much longer than conventional sunscreens because they comprise a Michael acceptor linked directly or indirectly to a chromo...
|
|
WO/1995/010266 |
A nitrogen monoxide synthesis inhibitor containing as the active ingredient at least one member selected from phenanthrene derivatives represented by the compounds of general formula (1) and salts thereof; it is useful for preventing and...
|
|
WO/1995/005164 |
Particles of ubidecarenone or of other poorly water-soluble substances, optionally containing additives, characterized in that the poorly water-soluble substance which is solid, preferably crystalline, in the bulk phase, is at least part...
|
|
WO/1995/002572 |
The present invention relates to a process for preparing 5,8-dihydronaphthoquinone derivatives represented by general formula (I) in which R1 represents alkyl or alkenyl, R2 represents hydrogen, alkyl or a group -C(O)R wherein R represen...
|
|
WO/1994/017055 |
The present invention provides novel antiviral naphthoquinone compounds, which may be isolated from plants of the genus Conospermum or synthesized chemically, in accordance with the present inventive methods. The antiviral naphthoquinone...
|
|
WO/1994/015258 |
A polymer has at least one photoactive site and more than one perfluorocyclobutane group. New monomers containing photoactive sites or photoactive precursors and at least one perfluorovinyl group are useful for making such polymers. Proc...
|
|
WO/1994/014426 |
The invention relates to microfluidised particles of atovaquone and to a method of preparing them. More particularly, the invention is concerned with a pharmaceutical composition containing microfluidised particles of atovaquone which ha...
|
|
WO/1994/012458 |
A saintopin E derivative represented by general formula (I) and useful as an antibacterial and antitumor agent, wherein when R1 represents hydrogen, then R2 represents SO2OH (in the case of UCE1022), while when R1 represents acetyl, then...
|
|
WO/1993/024650 |
The present invention relates generally to therapeutic compositions comprising one or more redox compounds. The therapeutic compositions of the present invention are useful in enhancing cellular ATP production thereby ameliorating the ef...
|
|
WO/1993/015607 |
Ion pairs of hypericin and its analogues and derivatives are prepared by acidifying hypericin to its free acid form and reacting with a predetermined quantity of an organic or inorganic base at a pH below about 11.5. The compounds are us...
|
|
WO/1993/008797 |
T cell-mediated diseases in mammals are treated using compositions comprising a polycyclic aromatic compound, preferably hypericin, pseudohypericin, and isomers, analogs, derivatives, salts, or ion pairs of hypericin or pseudohypericin. ...
|
|
WO/1993/002710 |
The present invention provides the use of a persistent aryloxy or arylthio free radicals, other than perhalo radicals, for the manufacture of a contrast medium for use in magnetic resonance imaging. Also provided are magnetic resonance i...
|
|
WO/1993/002711 |
The present invention provides the use of a persistent $g(p)-system free radical for the manufacture of a contrast medium for use in magnetic resonance imaging, wherein the electron delocalising $g(p)-system of said radical comprises at ...
|
|
WO/1992/012114 |
A process for producing an aromatic hydroxy compound by oxidizing directly an aromatic compound with an oxidizing agent, wherein the reaction is conducted in the presence of a catalyst comprising at least one platinum-group metal or its ...
|
|
WO/1992/007814 |
The invention relates to w-(1,4-quinonyl)-alkanals with a -(CH¿2?)¿n?-CHO side chain in the 2nd or 3rd position, wherein n is a whole number from 7 to 15. Process for making them and the use of such or other alkanals as substrates for ...
|
|
WO/1992/001448 |
Ubidecarenone is effective in curing sleep apnea in a dose of 1 to 3,000 mg per day for adult. It is particularly effective to administer 2 to 50 mg thereof before sleep.
|
|
WO/1991/013855 |
A novel phenanthrene derivative of general formula (1), its salt, a compound further derived therefrom, and its salt; a process for the production thereof; and an interleukin 1 (IL-1) inhibitor containing the derivative as the active ing...
|
|
WO/1991/008189 |
Polyhydroxy-1,4-naphthoquinones of general formula (I), where, with R1 = R2 = hydroxy group, R3 = tret.butyl and R4 = hydrogen, or R3 = hydroxy group and R4 = propyl or 2-carboxyethyl; with R1 = R2 = 2-hydroxyethyl group, R3 = hydroxy gr...
|
